The probiotic infant and child formula in Asia Pacific is expected to grow from US$ 9,175.81 million in 2022 to US$ 20,548.46 million by 2028. It is estimated to grow at a CAGR of 14.4% from 2022 to 2028.

Rising Demand for Organic Infant Formula

In recent years, there has been a growing demand for natural or organic products in the infant formula market. Parents’ interest in organic nutrition for infants and environmental sustainability is expected to boost the demand for organic infant formula. The addition of organic ingredients in the probiotic formula addresses parents’ concerns about product safety and environmental sustainability. Various brands are promoting ‘natural claims’ to gain an organic position in the market. The larger brands present in the Asia Pacific probiotic infant and child formula market have started embracing the organic and sustainable message, leading to the increased development of organic infant formula products. For instance, HiPP International has developed an organic baby formula that contains prebiotics, probiotics, and other finest quality and organic ingredients to provide all the nourishment to the infant. Similarly, Wellements provides organic probiotic drops that support the child’s digestive and immune health. Thus, a growing inclination toward the consumption of organic infant formula is expected to provide growth opportunities for the Asia Pacific probiotic infant and child formula market.

Market Overview

Asia Pacific is home to 60% of the world’s population, nearly 4.3 billion people, and includes the world’s most populous countries, China and India. The region is expected to exhibit significant growth during the forecast period due to increasing spending by new mothers on nutritious food for a child and rising purchasing capacity of people in the region. India and China have the highest number of births per woman than other countries as per the report by the World Bank in 2020. This is anticipated to augment the demand for probiotic infant and child formula in Asia Pacific during the forecast period.

Asia Pacific Probiotic Infant and Child Formula Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Probiotic Infant and Child Formula Market Segmentation

The Asia Pacific probiotic infant and child formula is segmented into type, distribution channel, and country.

Based on type, the market is segmented into infant formula (0-1 year) and growing-up formula (1-6 years). The growing-up formula (1-6 years) segment registered the larger market share in 2022. Based on distribution channel , the market is segmented into online and offline. The offline segment held the larger market share in 2022. Based on country, the market is segmented into Australia ,China, Japan , New Zealand and Rest of Asia Pacific. China dominated the market share in 2022. Nestlé S.A. ; HiPP GmbH & Company Vertrieb KG ; Abbott Laboratories and Mead Johnson & Company, LLC ; and Bellamy’s Organic are the leading companies operating in the probiotic infant and child formula in the region.

TABLE OF CONTENTS

1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
2. Key Takeaways
3. Research Methodology
3.1 Scope of the Study
3.2 Research Methodology
3.2.1 Data Collection:
3.2.2 Primary Interviews:
3.2.3 Hypothesis Formulation:
3.2.4 Macro-economic Factor Analysis:
3.2.5 Developing Base Number:
3.2.6 Data Triangulation:
3.2.7 Country Level Data:
4. Asia Pacific Probiotic Infant and Child Formula Market Landscape
4.1 Market Overview
4.2 Porter’s Five Forces Analysis
4.2.1 Threat of New Entrants
4.2.2 Bargaining Power of Suppliers
4.2.3 Bargaining Power of Buyers
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes
4.3 Expert Opinion
5. Asia Pacific Probiotic Infant and Child Formula Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Focus on Infant Care and Nutrition
5.1.2 Surge in Working Women Population
5.2 Market Restraints
5.2.1 Stringent Rules and Regulations Pertaining to Infant Formula
5.3 Market Opportunities
5.3.1 Rising Demand for Organic Infant Formula
5.4 Future Trends
5.4.1 Innovations in Probiotic Infant and Child Formula Market
5.5 Impact Analysis of Drivers and Restraints
6. Probiotic Infant and Child Formula – Asia Pacific Market Analysis
6.1 Asia Pacific Probiotic Infant and Child Formula Market Overview
6.2 Asia Pacific Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
7. Asia Pacific Probiotic Infant and Child Formula Market Analysis – by Type
7.1 Overview
7.2 Asia Pacific Probiotic Infant and Child Formula Market, by Type (2021 and 2028)
7.3 Infant Formula (0-1 Year)
7.3.1 Overview
7.3.2 Asia Pacific Infant Formula (0-1 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Growing-Up Formula (1-6 Years)
7.4.1 Overview
7.4.2 Asia Pacific Growing-Up Formula (1-6 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
8. Asia Pacific Probiotic Infant and Child Formula Market Analysis – by Distribution Channel
8.1 Overview
8.2 Asia Pacific Probiotic Infant and Child Formula Market, by Distribution Channel (2021 and 2028)
8.3 Online
8.3.1 Overview
8.3.2 Asia Pacific Online: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Offline
8.4.1 Overview
8.4.2 Asia Pacific Offline: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
9. Asia Pacific Probiotic Infant and Child Formula Market – Country Analysis
9.1 Asia Pacific: Probiotic Infant and Child Formula Market
9.1.1 Asia Pacific: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2 Asia Pacific: Probiotic Infant and Child Formula Market, by Key Country
9.1.2.1 Australia: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2.1.1 Australia: Probiotic Infant and Child Formula Market, By Type
9.1.2.1.2 Australia: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.2 China: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2.2.1 China: Probiotic Infant and Child Formula Market, By Type
9.1.2.2.2 China: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.3 Japan: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2.3.1 Japan: Probiotic Infant and Child Formula Market, By Type
9.1.2.3.2 Japan: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.4 New Zealand: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2.4.1 New Zealand: Probiotic Infant and Child Formula Market, by Type
9.1.2.4.2 New Zealand: Probiotic Infant and Child Formula Market, by Distribution Channel
9.1.2.5 Rest of Asia Pacific: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
9.1.2.5.1 Rest of Asia Pacific: Probiotic Infant and Child Formula Market, By Type
9.1.2.5.2 Rest of Asia Pacific: Probiotic Infant and Child Formula Market, by Distribution Channel
10. Industry Landscape
10.1 Overview
10.2 New Product Development
11. Company Profiles
11.1 Nestlé S.A.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 HiPP GmbH & Company Vertrieb KG
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Abbott Laboratories
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Mead Johnson & Company, LLC.
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Bellamy’s Organic
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Word Index

LIST OF TABLES

Table 1. Asia Pacific Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Table 2. Asia Pacific Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 3. Asia Pacific: Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. Australia Probiotic Infant and Child Formula Market, By Type– Revenue and Forecast to 2028 (US$ Million)
Table 5. Australia Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 6. China Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 7. China Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 8. Japan Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 9. Japan Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 10. New Zealand Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. New Zealand Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of Asia Pacific Probiotic Infant and Child Formula Market, By Type – Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of Asia Pacific Probiotic Infant and Child Formula Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 14. List of Abbreviation

LIST OF FIGURES

Figure 1. Asia Pacific Probiotic Infant and Child Formula Market Segmentation
Figure 2. Asia Pacific Probiotic Infant and Child Formula Market Segmentation – By Country
Figure 3. Asia Pacific Probiotic Infant and Child Formula Market Overview
Figure 4. Asia Pacific Probiotic Infant and Child Formula Market: By Type
Figure 5. Asia Pacific Probiotic Infant and Child Formula Market: By Country
Figure 6. Porter’s Five Forces Analysis: Probiotic Infant and Child Formula Market
Figure 7. Expert Opinion
Figure 8. Asia Pacific Probiotic Infant and Child Formula Market Impact Analysis of Drivers and Restraints
Figure 9. Asia Pacific: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Asia Pacific: Probiotic Infant and Child Formula Market Revenue Share, By Type (2021 and 2028)
Figure 11. Asia Pacific Infant Formula (0-1 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Asia Pacific Growing-Up Formula (1-6 Year): Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Asia Pacific: Probiotic Infant and Child Formula Market Revenue Share, by Distribution Channel (2021 and 2028)
Figure 14. Asia Pacific Online: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Asia Pacific Offline: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Asia Pacific: Probiotic Infant and Child Formula Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Asia Pacific: Probiotic Infant and Child Formula Market Revenue Share, by Key Country (2021 and 2028)
Figure 18. Australia: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Figure 19. China: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Figure 20. Japan: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Figure 21. New Zealand: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)
Figure 22. Rest of Asia Pacific: Probiotic Infant and Child Formula Market –Revenue and Forecast to 2028 (US$ Million)

● Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific Probiotic Infant and Child Formula Market.
● Highlights key business priorities in order to assist companies to realign their business strategies.
● The key findings and recommendations highlight crucial progressive industry trends in Asia Pacific Probiotic Infant and Child Formula Market, thereby allowing players across the value chain to develop effective long-term strategies.
● Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
● Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
● Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

The List of Companies – Asia Pacific Probiotic Infant and Child Formula Market

● Nestlé S.A.                                                                         
● HiPP GmbH & Company Vertrieb KG                                      
● Abbott Laboratories                                                                      
● Mead Johnson & Company, LLC     
● Bellamy’s Organic           

At 14.4% CAGR, the Asia Pacific Probiotic Infant and Child Formula Market is speculated to be worth US$ 20,548.46 million by 2028, says The Insight Partners

According to The Insight Partners’ research, the Asia Pacific probiotic infant and child formula market was valued at US$ 9,175.81 million in 2022 and is expected to reach US$ 20,548.46 million by 2028, registering an annual growth rate of 14.4% from 2022 to 2028. Growing focus on infant care and nutrition and surge in working women population are the critical factors attributed to the market expansion.

In recent years, there has been an increased focus on infant care and providing the optimum amount of nutrition to the child as it will boost the child’s early development. Further, different brain processes such as myelination will require different nutrients, and the deficiency of such nutrients during the peak growth period will have a detrimental impact on the child. Thus, the need for the right nutrient at an early stage of a child’s life is driving the demand for probiotic infant and child formula. Parents are increasingly providing probiotics and vitamin supplements to their children to improve their digestive health, general health, immune system, and heart health. Furthermore, the inclusion of probiotics in infant formulas promotes a balance of good bacteria in the child’s intestines and offsets the growth of “unfriendly” organisms that could cause infections and inflammation. Thus, the growing focus on infant care and nutrition is driving the growth of the Asia Pacific probiotic infant and child formula market.

On the contrary, stringent rules and regulations pertaining to infant formula hampers market Asia Pacific probiotic infant and child formula market.

Based on type, the market is segmented into infant formula (0-1 year) and growing-up formula (1-6 years). The growing-up formula (1-6 years) segment held 72.21% market share in 2022, amassing US$ 6,625.76 million. It is projected to garner US$ 15,107.19 million by 2028 to expand at 14.7% CAGR during 2022–2028. Based on distribution channel, the market is segmented into online and offline. The offline segment held 84.34% market share in 2022, amassing US$ 7,738.81 million. It is projected to garner US$ 17,091.93 million by 2028 to expand at 14.1% CAGR during 2022–2028. Based on country, the Asia Pacific probiotic infant and child formula market has been categorized into Australia, China, Japan, New Zealand and Rest of Asia Pacific. Our regional analysis states that China captured 66.47% market share in 2022. It was assessed at US$ 6,099.08 million in 2022 and is likely to hit US$ 13,484.16 million by 2028, exhibiting a CAGR of 14.1% during the forecast period. Key players dominating the Asia Pacific probiotic infant and child formula market are Nestlé S.A. ; HiPP GmbH & Company Vertrieb KG ; Abbott Laboratories and Mead Johnson & Company, LLC ; and Bellamy’s Organic.

In, 2022; Nestle China launched new infant formula via CBEC. In ,2021; Abbott Laboratories ABT launched the Similac 360 Total Care.